Zhejiang Conba Pharmaceutical Co.,Ltd.’s Net Profit Rose 118.8% in First Half of 2023

Zhejiang Conba Pharmaceutical Co.,Ltd. (浙江康恩贝制药股份有限公司) (600572.SH) reported a net profit of 575.6 million yuan in the first half of 2023, up 118.8% year-on-year.

Meanwhile, the company posted 3.8 billion yuan in revenue, up 22.2% year-on-year.

At the end of the reporting period, it had 11.5 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 35.7%.